TrademarkDir
BIOTECHNOLOGY WITH A FOCUS ON EYE DISEASE
DEAD

Serial Number

78416598

Owner

Eyetech Pharmaceuticals, Inc.

Attorney

Michael J. Rafa

Filing Date

May 11, 2004

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BIOTECHNOLOGY WITH A FOCUS ON EYE DISEASE Trademark

Serial Number: 78416598

BIOTECHNOLOGY WITH A FOCUS ON EYE DISEASE is a trademark filed by Eyetech Pharmaceuticals, Inc. on May 11, 2004. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Eyetech Pharmaceuticals, Inc. (20 trademarks)

3 TIMES SQUARE 12TH FLOOR
New York, NY 10036

Entity Type: 03

(OSI) EYETECH, INC. (29 trademarks)

3 TIMES SQUARE
NEW YORK, NY 10036

Entity Type: 03

Trademark Details

Filing Date

May 11, 2004

Registration Date

Not Registered

Published for Opposition

October 4, 2005

Goods & Services

Pharmaceutical preparations for the treatment of ocular diseases and delivery devices sold as a unit therewith, namely, injectable syringes used for administering these preparations to a subject

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 30, 2006 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 30, 2006 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 27, 2005 NOAM
PUBLISHED FOR OPPOSITION
Oct 4, 2005 PUBO
NOTICE OF PUBLICATION
Sep 14, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 20, 2005 PREV
ASSIGNED TO LIE
Jun 17, 2005 ALIE
EXAMINERS AMENDMENT MAILED
Jun 15, 2005 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 14, 2005 CNSA
EXAMINERS AMENDMENT -WRITTEN
Jun 14, 2005 CNEA
AMENDMENT FROM APPLICANT ENTERED
Jun 9, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2005 CRFA
PAPER RECEIVED
May 24, 2005 MAIL
EXAMINER'S AMENDMENT AND/OR PRIORITY ACTION MAILED
Dec 14, 2004 CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Dec 13, 2004 CPEA
ASSIGNED TO EXAMINER
Dec 9, 2004 DOCK
NEW APPLICATION ENTERED
May 18, 2004 NWAP

Related Trademarks

More from this Owner

LEVEL

LEVEL

LEVEL

LEVEL

LEVEL

LEVEL

LEVEL

LEVEL

LEVEL

LEVEL

LEVEL

LEVEL